NanoVibronix Weighted Average Shares Diluted from 2010 to 2024
| NAOV Stock | USD 0.80 0.04 5.26% |
Check NanoVibronix financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NanoVibronix main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.1 K, Interest Expense of 128.2 K or Selling General Administrative of 2.4 M, as well as many exotic indicators such as Price To Sales Ratio of 0.84, Dividend Yield of 0.0 or PTB Ratio of 0.53. NanoVibronix financial statements analysis is a perfect complement when working with NanoVibronix Valuation or Volatility modules.
NanoVibronix | Weighted Average Shares Diluted |
About NanoVibronix Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include NanoVibronix income statement, its balance sheet, and the statement of cash flows. NanoVibronix investors use historical funamental indicators, such as NanoVibronix's Weighted Average Shares Diluted, to determine how well the company is positioned to perform in the future. Although NanoVibronix investors may use each financial statement separately, they are all related. The changes in NanoVibronix's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on NanoVibronix's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on NanoVibronix Financial Statements. Understanding these patterns can help to make the right decision on long term investment in NanoVibronix. Please read more on our technical analysis and fundamental analysis pages.
NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. NanoVibronix, Inc. was incorporated in 2003 and is based in Elmsford, New York. Nanovibronix operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 12 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards NanoVibronix in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, NanoVibronix's short interest history, or implied volatility extrapolated from NanoVibronix options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of NanoVibronix Correlation against competitors. For more information on how to buy NanoVibronix Stock please use our How to Invest in NanoVibronix guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Complementary Tools for NanoVibronix Stock analysis
When running NanoVibronix's price analysis, check to measure NanoVibronix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NanoVibronix is operating at the current time. Most of NanoVibronix's value examination focuses on studying past and present price action to predict the probability of NanoVibronix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NanoVibronix's price. Additionally, you may evaluate how the addition of NanoVibronix to your portfolios can decrease your overall portfolio volatility.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |
Is NanoVibronix's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NanoVibronix. If investors know NanoVibronix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NanoVibronix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.12) | Revenue Per Share 1.304 | Quarterly Revenue Growth 3.722 | Return On Assets (0.31) | Return On Equity (1.03) |
The market value of NanoVibronix is measured differently than its book value, which is the value of NanoVibronix that is recorded on the company's balance sheet. Investors also form their own opinion of NanoVibronix's value that differs from its market value or its book value, called intrinsic value, which is NanoVibronix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NanoVibronix's market value can be influenced by many factors that don't directly affect NanoVibronix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NanoVibronix's value and its price as these two are different measures arrived at by different means. Investors typically determine if NanoVibronix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NanoVibronix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.